# ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy

> **NCT02973802** · PHASE1 · COMPLETED · sponsor: **Apitope International NV** · enrollment: 12 (actual)

## Conditions studied

- Graves Disease

## Interventions

- **BIOLOGICAL:** ATX-GD-59

## Key facts

- **NCT ID:** NCT02973802
- **Lead sponsor:** Apitope International NV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2018-02-14
- **Final completion:** 2018-02-14
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-06-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02973802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02973802, "ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02973802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*